Research Shows Connection Between Tubal Ligation, Cervical Cancer

Key points
- Women who have a tubal ligation – the surgical tying or severing of fallopian tubes to prohibit pregnancy – have less frequent Pap smears, which puts them at an increased risk for cervical cancer, according to research recently released by a team that included Cara A.
- Women & Infants Hospital of Rhode Island, a Care New England hospital, is one of the nation's leading specialty hospitals for women and newborns.
- The findings were part of the National Cancer Institute-funded study "Study to Understand Cervical Cancer Endpoints and Determinants" being conducted when Dr.
- Mathews, was to investigate any connection between different types of contraception, screening frequency and cancer rates.
Women who have a tubal ligation – the surgical tying or severing of fallopian tubes to prohibit pregnancy – have less frequent Pap smears, which puts them at an increased risk for cervical cancer, according to research recently released by a team that included Cara A. Mathews, MD, a gynecologic oncologist at the Program in Women's Oncology at Women & Infants Hospital of Rhode Island.
The findings were part of the National Cancer Institute-funded study "Study to Understand Cervical Cancer Endpoints and Determinants" being conducted when Dr. Mathews was a fellow at the University of Oklahoma. The results were published in late 2012 in the professional journal Gynecologic Oncology.
The objective, according to Dr. Mathews, was to investigate any connection between different types of contraception, screening frequency and cancer rates. Study participants were women who underwent a colposcopy after having an abnormal Pap test. The researchers used a questionnaire to identify factors associated with the cancer, including the frequency that the women went for Pap tests.
A Pap test checks for changes in the cells of a woman's cervix. The test can tell if the woman has an infection, abnormal cervical cells or cervical cancer, and has led to a major decline in the number of cervical cancer cases and deaths.
"Previously, we have advised women to have a Pap test every two years starting at age 21," Dr. Mathews explains. "Women over the age of 30 with three or more normal Pap tests were able to space screening intervals to every three years. And women over 65 without risk factors do not need to keep screening."
She and her colleagues, however, discovered that women who have had a tubal ligation were not as likely to have regular Pap tests.
"In all age groups, women with tubal ligation were more likely to have had no Pap screening in the previous five years compared to women using other forms of contraception," Dr. Mathews reveals.
The research publication came on the tail of new recommended Pap guidelines from the American College of Gynecology (ACOG), which state that women between 21 and 65 without risk factors should be screened every three years. Women ages 30 to 65 who want to extend the screening interval can go every five years.
"In issuing the new guidelines, ACOG stressed the importance of emphasizing well visits and screenings in women, including the Pap test, to promote health and prevent cancer," Dr. Mathews concludes.
For more information about personal testing, women can call their gynecologist or family care practitioner. For a list of physicians accepting new patients, they can call Women & Infants' Physician Referral Line at 1-800-921-9299. Women diagnosed with cervical cancer or who have had an abnormal Pap test can be referred to the Program in Women's Oncology at (401) 453-7520.
###
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsResearchers find experimental drug can help fight debilitating side effect of ovarian cancer
Women who have ovarian cancer often develop a condition called ascites, which is a buildup of fluids in the abdomen. The most common treatment for ascites is puncturing the abdomen and manually draining the fluid, which…
18 November 2015
NewsPotential new therapy for triple-negative breast cancer shows promise in lab studies
Recent laboratory findings provide novel insight into potential new therapeutic approaches for triple-negative breast cancer, a particularly difficult to treat and aggressive form of the disease. In a recent study…
28 October 2015
NewsThe CNIO discovers a link between a rare form of anemia and cancer
Researchers from the Tumour Suppression Group at the Spanish National Cancer Research Centre (CNIO), headed by Manuel Serrano, have discovered the molecular mechanisms that determine cancer predisposition in patients…






